Ownership history in RENAISSANCE TECHNOLOGIES LLC · 43 quarters on record
This page tracks every 13F SEC filing in which RENAISSANCE TECHNOLOGIES LLC reported a position in CASI PHARMACEUTICALS INC (CASI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 43,100 | -800 | -1.8% | 0.00% | $37K | $0.85 |
| 2025 Q3 | ADDED | 43,900 | +4,700 | +12.0% | 0.00% | $73K | $1.66 |
| 2025 Q2 | ADDED | 39,200 | +300 | +0.8% | 0.00% | $46K | $1.18 |
| 2025 Q1 | REDUCED | 38,900 | -500 | -1.3% | 0.00% | $84K | $2.16 |
| 2024 Q4 | REDUCED | 39,400 | -2,100 | -5.1% | 0.00% | $112K | $2.83 |
| 2024 Q3 | ADDED | 41,500 | +700 | +1.7% | 0.00% | $256K | $6.16 |
| 2024 Q2 | ADDED | 40,800 | +4,000 | +10.9% | 0.00% | $224K | $5.50 |
| 2024 Q1 | ADDED | 36,800 | +7,700 | +26.5% | 0.00% | $133K | $3.61 |
| 2023 Q4 | ADDED | 29,100 | +11,300 | +63.5% | 0.00% | $208K | $7.16 |
| 2023 Q3 | ADDED | 17,800 | +2,700 | +17.9% | 0.00% | $46K | $2.56 |
As of 2025 Q4 — sorted by position size